Next-generation sequencing demonstrated that the family had compound heterozygous mutations in <i>COL1A1</i> and <i>COL1A2</i>, with no known mutations related to PSIS, pituitary hormone deficiency (PHD), or holoprosencephaly (HPE). The gene discussed is COL1A2; the disease is pituitary stalk interruption syndrome.